Healthcare AI Acquisition Corp., a blank check company focused on effectuating mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations, has released its Form 10-Q report for the quarter ending June 30, 2025. The report provides insights into the company's financial performance and operational activities during the period.
Financial Highlights
- Net Income: The company reported a net loss of $542,059 for the three months ended June 30, 2025, primarily due to a decrease in interest income following significant redemptions from the Trust Account.
- Net Income: For the six months ended June 30, 2025, the company recorded a net loss of $616,178, driven by operating costs and changes in the fair value of warrant liability.
- Net Income: In comparison, the company had a net income of $145,656 for the three months ended June 30, 2024, largely due to interest income from investments held in the Trust Account.
- Net Income: For the six months ended June 30, 2024, the company experienced a net loss of $321,060, impacted by changes in the fair value of warrant liability.
Business Highlights
- Company Overview: Healthcare AI Acquisition Corp. is a blank check company formed to effectuate a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. As of the report date, the company has not selected any business combination target.
- Initial Public Offering: The company completed its Initial Public Offering on December 14, 2021, raising gross proceeds of $200 million through the sale of 20,000,000 units, with an additional $15.6 million from the sale of over-allotment units.
- Trust Account Management: Following the IPO, $219.9 million was placed in a trust account, invested in U.S. government securities or money market funds, to be used for a future business combination.
- Sponsor Handover: On June 12, 2023, the company transitioned sponsorship from Healthcare AI Acquisition, LLC to Atticus Ale, LLC, which included a transfer of founder shares and amendments to the company's Articles of Association.
- Redemption Activity: Significant redemptions occurred following the Sponsor Handover, with 19,824,274 shares redeemed at $10.54 per share, and additional redemptions in subsequent shareholder meetings, impacting the trust account balance.
- Business Combination Agreement: On August 15, 2024, the company entered into a Business Combination Agreement with Leading Partners Limited and Leading Group Limited, a provider of insurance products in China. The agreement involves exchanging company shares for Holdco Class A shares.
- Nasdaq Delisting: The company received a notice from Nasdaq on December 10, 2024, for non-compliance with listing requirements, leading to the suspension of its securities from trading on Nasdaq and subsequent trading on OTC Markets.
- Future Outlook: The company has until October 14, 2025, to consummate a business combination, with extensions available on a month-to-month basis. The management acknowledges substantial doubt about the company's ability to continue as a going concern if a business combination is not completed by the termination date.
SEC Filing: